Research Analysts’ New Coverage for October 12th (ABCL, ABTC, AMRZ, ASBH, AXGN, CHMG, CNTB, EQ, GOAI, HIG)

Research Analysts’ new coverage for Monday, October 12th:

UBS Group AG assumed coverage on shares of AbCellera Biologics (NASDAQ:ABCL). They issued a buy rating and a $18.00 price target on the stock.

HC Wainwright began coverage on shares of American Bitcoin (NASDAQ:ABTC). HC Wainwright issued a buy rating and a $22.00 price target on the stock.

Longbow Research assumed coverage on shares of Amrize (NYSE:AMRZ). They issued a buy rating on the stock.

Stephens initiated coverage on shares of American Savings Bank of Hawaii (NYSE:ASBH). The firm issued an overweight rating and a $21.00 price target on the stock.

Keefe, Bruyette & Woods initiated coverage on shares of American Savings Bank of Hawaii (NYSE:ASBH). The firm issued a market perform rating and a $19.00 price target on the stock.

Bank of America Corporation began coverage on shares of AxoGen (NASDAQ:AXGN). They issued a buy rating and a $52.00 target price on the stock.

Hovde Group assumed coverage on shares of Chemung Financial (NASDAQ:CHMG). They issued a market perform rating and a $88.00 price target on the stock.

Leerink Partners started coverage on shares of Connect Biopharma (NASDAQ:CNTB). Leerink Partners issued an outperform rating and a $4.00 target price on the stock.

Leerink Partners began coverage on shares of Equillium (NASDAQ:EQ). The firm issued an outperform rating and a $6.00 price target on the stock.

Maxim Group initiated coverage on shares of Eva Live (NASDAQ:GOAI). They issued a buy rating and a $7.00 target price on the stock.

Truist Financial Corporation initiated coverage on shares of The Hartford Insurance Group (NYSE:HIG). Truist Financial Corporation issued a hold rating and a $137.00 target price on the stock.

Deutsche Bank Aktiengesellschaft initiated coverage on shares of Interactive Brokers Group (NASDAQ:IBKR). Deutsche Bank Aktiengesellschaft issued a buy rating and a $102.00 target price on the stock.

Citigroup Inc. began coverage on shares of Las Vegas Sands (NYSE:LVS). They issued a buy rating and a $71.50 target price on the stock.

Citigroup Inc. started coverage on shares of Melco Resorts & Entertainment (NASDAQ:MLCO). The firm issued a buy rating and a $9.40 price target on the stock.

Maxim Group started coverage on shares of Everspin Tech (NASDAQ:MRAM). The firm issued a buy rating and a $25.00 target price on the stock.

Leerink Partners assumed coverage on shares of Nektar Therapeutics (NASDAQ:NKTR). They issued an outperform rating and a $130.00 target price on the stock.

Leerink Partners initiated coverage on shares of Q32 Bio (NASDAQ:QTTB). The firm issued an outperform rating and a $40.00 target price on the stock.

Evercore Inc initiated coverage on shares of Charles Schwab (NYSE:SCHW). The firm issued an in-line rating and a $107.00 target price on the stock.

Hovde Group assumed coverage on shares of First Financial Corporation Indiana (NASDAQ:THFF). The firm issued an outperform rating and a $85.00 target price on the stock.

Leerink Partners started coverage on shares of Vera Therapeutics (NASDAQ:VERA). The firm issued a market perform rating and a $34.00 target price on the stock.

Receive News & Ratings for AbCellera Biologics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbCellera Biologics Inc and related companies with MarketBeat.com's FREE daily email newsletter.